Scientific Papers


AIER – American Institute for Economic Research – The Dangers of Masks


Brownstone Institute – How Dangerous Are Masks for Children?

Early Treatment

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)


Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection


Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents


Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infection


Early multidrug regimens in new potentially fatal medical problems

Vaccine efficacy/safety/dangers

Neurotoxicity of COVID vaccine and damage to innate immune system


Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of

G-quadruplexes, exosomes, and MicroRNAs


This demonstrates prion-like capabilities of the spike protein:

Amyloidogenesis of SARS-CoV-2 Spike Protein


This shows upregulation of alpha synuclein and increased risk to

Parkinson’s disease:

SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro


This is an important paper showing that the spike protein activates toll

like receptor 4, which leads to a strong inflammatory response.

SARS-CoV-2 spike protein interacts with and activates TLR41


This shows that spike subunit S1 alone is neurotoxic

SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties


This shows that spike has a sequence that resembles a toxic enterotoxin

produced by Staph aureus.

A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro


Shows spike still present 15 months post-infection

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection


Spike still present several months after vaccination

SARS-CoV-2 S1 Protein Persistence in SARS-CoV-2 Negative Post-Vaccination Individuals with Long COVID/ PASC-Like Symptoms

Skip to content